The post ASGCT 2026: Process Development, Technology Transfer, Clinical Manufacturing, and Process Characterization of AFTX-201, an Investigational New Medicine for the Treatment of BAG3-Associated Dilated Cardiomyopathy appeared first on AffiniaTX .